exelixis shares fall on cancer drug safety concerns
shares of exelixis inc fell 20 percent on monday after the company reported data over the weekend showing that its experimental cancer drug caused the deaths of six patients in a clinical trial.
http://feeds.reuters.com/~r/reuters/healthnews/~3/ibk-cz8mjye/us-exelixis-idustre75530520110606
33081
06 Jun 2011 22:49:33
reuters
health